oxotremorine sesquifumarate,
Oxotremorine sesquifumarate salt,
Oxotremorine fumarate (2:3),
17360-35-9,
EINECS 241-388-3,
1-(N-(1-Pyrrolidinyl)-2-butynyl)-2-pyrrolidinone sesquifumarate,
1-(4-[1-Pyrrolidinyl]2-butynyl)-2-pyrrolidinone,
1-[4-(1-Pyrrolidinyl)-2-butynyl]-2-pyrrolidinone sesquifumarate,
2-Pyrrolidinone, 1-(4-(1-pyrrolidinyl)-2-butynyl)-, sesquifumarate,
Bis(1-(4-(pyrrolidin-1-yl)but-2-ynyl)pyrrolidin-2-one) trifumarate,
AC1O5LQH,
CHEMBL1551988,
oxotremorine ses-quifumarate salt,
HMS3262H10,
HMS3266J20,
HMS3675P09,
Tox21_500914,
MFCD00013163,
AKOS024458667,
tris(fumaric acid); bis(oxotremorine),
CCG-222218,
LP00914,
2-Pyrrolidinone, 1-(4-(1-pyrrolidinyl)-2-butynyl)-, (E)-2-butenedioate (2:3),
NCGC00094225-01,
NCGC00261599-01,
tris(butenedioic acid); bis(oxotremorine),
LS-139011,
EU-0100914,
O 9126,
Oxotremorine sesquifumarate salt, >=98% (HPLC), solid,
1-(4-(Pyrrolidin-1-yl)but-2-yn-1-yl)pyrrolidin-2-one sesquifumarate,
2-Pyrrolidinone, 1-(4-(1-pyrrolidinyl)-2-butynyl)-, fumarate (2:3),
2-Pyrrolidinone, 1-(4-(1-pyrrolidinyl)-2-butynyl)-, (E)-2-butenedioate (2:3) (9CI),
2-Pyrrolidinone, 1-(4-(1-pyrrolidinyl)-2-butynyl)-, fumarate (2:3) (8CI),
2-Pyrrolidinone, 1-[4-(1-pyrrolidinyl)-2-butyn-1-yl]-, (2E)-2-butenedioate (2:3),
bis(1-[4-(pyrrolidin-1-yl)but-2-yn-1-yl]pyrrolidin-2-one); tris(but-2-enedioic acid),
oxotremorine sesquifumarate,
C12H18N2O,
CID6436473,
C12H18N2O.3/2C4H4O4,
1-(4-[1-Pyrrolidinyl]-2-butynyl)-2-pyrrolidinone,
C12-H18-N2-O.3/2C4-H4-O4,
(E)-but-2-enedioic acid; 1-(4-pyrrolidin-1-ylbut-2-ynyl)pyrrolidin-2-one,
2-Pyrrolidinone, 1-[4-(1-pyrrolidinyl)-2-butynyl]-, fumarate (2:3),
Bis[1-[4-(pyrrolidin-1-yl)but-2-ynyl]pyrrolidin-2-one] trifumarate,
2-Pyrrolidinone, 1-[4-(1-pyrrolidinyl)-2-butynyl]-, (E)-2-butenedioate (2:3),